{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:31:43Z","timestamp":1782603103807,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T00:00:00Z","timestamp":1545696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jfma.2018.12.023","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T21:24:56Z","timestamp":1546982696000},"page":"1537-1545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3660-4087","authenticated-orcid":false,"given":"Chien-Ting","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hwei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3660-1062","authenticated-orcid":false,"given":"Ming-Chih","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1832-8509","authenticated-orcid":false,"given":"Hsiu-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiann-Tarng","family":"Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hsuan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huey-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2018.12.023_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/01.TP.0000057244.03192.BD","article-title":"Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment","volume":"75","author":"Guthery","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jfma.2018.12.023_bib2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/TP.0b013e318198d645","article-title":"Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children","volume":"87","author":"Wu","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jfma.2018.12.023_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/lt.23659","article-title":"Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience","volume":"19","author":"Narkewicz","year":"2013","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00007890-199608150-00012","article-title":"Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression","volume":"62","author":"Newell","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jfma.2018.12.023_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1399-3046.2008.00914.x","article-title":"Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome","volume":"13","author":"Fernandez","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib6","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/j.1600-6143.2005.01002.x","article-title":"Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients","volume":"5","author":"Lee","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib7","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jfma.2018.12.023_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00043426-200101000-00005","article-title":"Posttransplant lymphoproliferative disease in children: correlation of histology to clinical behavior","volume":"23","author":"Hayashi","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jfma.2018.12.023_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00005176-200204000-00014","article-title":"Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients","volume":"34","author":"Serinet","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jfma.2018.12.023_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00043426-200101000-00003","article-title":"Treatment of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders","volume":"23","author":"Gross","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jfma.2018.12.023_bib11","first-page":"492","article-title":"Cyclosphosphamide\/prednisone for combination immunosuppression and therapy of lymphoproliferative disease","volume":"18","author":"Balfour","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib12","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2018.12.023_bib13","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.transproceed.2009.07.048","article-title":"Posttransplant lymphoproliferative disease in pediatric liver transplant recipients","volume":"41","author":"Sevmis","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jfma.2018.12.023_bib14","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.transproceed.2009.06.132","article-title":"Posttransplant lymphoproliferative disorder in pediatric liver transplantation","volume":"41","author":"Uribe","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jfma.2018.12.023_bib15","doi-asserted-by":"crossref","first-page":"e0115836","DOI":"10.1371\/journal.pone.0115836","article-title":"A large-scale seroprevalence of Epstein-Barr virus in Taiwan","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2018.12.023_bib16","first-page":"81","article-title":"Seroepidemiological study of Epstein-Barr virus infection in children in Taipei","volume":"30","author":"Tsai","year":"1989","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"key":"10.1016\/j.jfma.2018.12.023_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1399-0012.2010.01392.x","article-title":"Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990\u20132009","volume":"26","author":"Yoon","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1399-3046.2010.01370.x","article-title":"Post-transplant lymphoproliferative disorder in children: recent outcomes and response to dual rituximab\/low-dose chemotherapy combination","volume":"14","author":"Gupta","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOP.0000000000000445","article-title":"Management of post-transplant lymphoproliferative disorders","volume":"29","author":"Llaurador","year":"2017","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jfma.2018.12.023_bib20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/00007890-200003150-00053","article-title":"Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation","volume":"69","author":"Smets","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jfma.2018.12.023_bib21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00043426-200110000-00012","article-title":"Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation","volume":"23","author":"Suryanarayan","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jfma.2018.12.023_bib22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1200\/JCO.2001.19.3.772","article-title":"Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders","volume":"19","author":"Leblond","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jfma.2018.12.023_bib23","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1111\/ctr.12152","article-title":"Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience","volume":"27","author":"Mendizabal","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib24","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1200\/JCO.2005.01.0934","article-title":"Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders","volume":"23","author":"Ghobrial","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jfma.2018.12.023_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1600-6143.2005.00776.x","article-title":"Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience","volume":"5","author":"Trofe","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib26","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1200\/JCO.2006.10.2392","article-title":"CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation","volume":"25","author":"Maecker","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jfma.2018.12.023_bib27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.2010.08448.x","article-title":"CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation","volume":"152","author":"Orjuela","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jfma.2018.12.023_bib28","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.transproceed.2008.07.014","article-title":"Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation","volume":"40","author":"Jang","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jfma.2018.12.023_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-3046.2004.00129.x","article-title":"Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation","volume":"8","author":"Hurwitz","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.5500\/wjt.v6.i4.729","article-title":"Persistent Epstein-Barr viral load in Epstein-Barr viral naive pediatric heart transplant recipients: risk of late-onset post-transplant lymphoproliferative disease","volume":"6","author":"Das","year":"2016","journal-title":"World J Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1399-3046.2012.01713.x","article-title":"Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease","volume":"16","author":"Weiner","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib32","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1399-3046.2010.01357.x","article-title":"Long-term outcomes of pediatric living donor liver transplantation at a single institution","volume":"14","author":"Oh","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jfma.2018.12.023_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5223\/pghn.2013.16.4.207","article-title":"Long term outcomes after pediatric liver transplantation","volume":"16","author":"Yazigi","year":"2013","journal-title":"Pediatr Gastroenterol Hepatol Nutr"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664618300093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664618300093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T10:30:52Z","timestamp":1571394652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664618300093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0929664618300093"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2018.12.023","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2018.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}